-
Mashup Score: 23Human Neuron Model Paves the Way for New Alzheimer’s Therapies - 1 month(s) ago
Weill Cornell Medicine scientists have developed an innovative human neuron model that robustly simulates the spread of tau protein aggregates in the brain—a process that drives cognitive decline in Alzheimer’s disease and frontotemporal dementia.
Source: news.weill.cornell.eduCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 23Human Neuron Model Paves the Way for New Alzheimer’s Therapies - 1 month(s) ago
Weill Cornell Medicine scientists have developed an innovative human neuron model that robustly simulates the spread of tau protein aggregates in the brain—a process that drives cognitive decline in Alzheimer’s disease and frontotemporal dementia.
Source: news.weill.cornell.eduCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Specialized Nursing Facility Clinicians Improve End-of-Life Care - 2 month(s) ago
Specialized nursing facility clinicians, or SNFists, may decrease the likelihood of nursing home residents experiencing stressful hospitalizations and improve the quality of life in their last days, according to researchers from Weill Cornell Medicine.
Source: news.weill.cornell.eduCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 10
Researchers at Weill Cornell Medicine, Cornell Tech and Cornell’s Ithaca campus have demonstrated the use of AI-selected natural images and AI-generated synthetic images as neuroscientific tools for probing the visual processing areas of the brain.
Source: news.weill.cornell.eduCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 24Immune Protein May Induce Dementia Unrelated to High Blood Pressure - 5 month(s) ago
Researchers at Weill Cornell Medicine have found that controlling high blood pressure may not be enough to prevent associated cognitive declines. The findings point to an immune protein called cytokine IL-17 as a culprit for inducing dementia and suggest new approaches to prevent damage brain cells.
Source: news.weill.cornell.eduCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 24Appel Alzheimer's Disease Research Institute Symposium Highlights Progress Towards New Treatments - 5 month(s) ago
The 11th annual Appel Alzheimer’s Disease Research Institute Symposium brought together leading scientists and clinicians in the field to present the latest advances in understanding Alzheimer’s and related neurodegenerative diseases.
Source: news.weill.cornell.eduCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 51Cathy Garzio Named Executive Vice Provost and Chief Operating Officer of Weill Cornell Medicine - 6 month(s) ago
Garzio, a distinguished academic medicine administrator, will start her new role in early February.
Source: news.weill.cornell.eduCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 21New Culprit in Amyloid Beta Accumulation and Neurodegeneration - 6 month(s) ago
Researchers at Weill Cornell Medicine have demonstrated how amyloid beta, a peptide associated with Alzheimer’s disease, can interact with a protein receptor on immune cells in the brain triggering a reaction that damages blood vessels and leads to neurodegeneration.
Source: news.weill.cornell.eduCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 13
Estrogen-based menopause hormone therapy for women in mid-life should be investigated more thoroughly as a potential strategy for preventing Alzheimer’s disease, the most common form of dementia, according to a new analysis from researchers at Weill Cornell Medicine.
Source: news.weill.cornell.eduCategories: General Medicine News, General HCPsTweet
Human Neuron Model Paves the Way for New Alzheimer’s Therapies https://t.co/CqNZe5ROlA